7-74053320-CTGTGTGTGTGTGTGTGTGTGTGTG-CTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BS1_SupportingBS2

The NM_000501.4(ELN):​c.1096+43_1096+50dupGTGTGTGT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0028 ( 0 hom., cov: 0)
Exomes 𝑓: 0.0019 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

ELN
NM_000501.4 intron

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.780

Publications

3 publications found
Variant links:
Genes affected
ELN (HGNC:3327): (elastin) This gene encodes a protein that is one of the two components of elastic fibers. Elastic fibers comprise part of the extracellular matrix and confer elasticity to organs and tissues including the heart, skin, lungs, ligaments, and blood vessels. The encoded protein is rich in hydrophobic amino acids such as glycine and proline, which form mobile hydrophobic regions bounded by crosslinks between lysine residues. Degradation products of the encoded protein, known as elastin-derived peptides or elastokines, bind the elastin receptor complex and other receptors and stimulate migration and proliferation of monocytes and skin fibroblasts. Elastokines can also contribute to cancer progression. Deletions and mutations in this gene are associated with supravalvular aortic stenosis (SVAS) and autosomal dominant cutis laxa. [provided by RefSeq, Aug 2017]
ELN Gene-Disease associations (from GenCC):
  • cutis laxa, autosomal dominant 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, Genomics England PanelApp, G2P
  • supravalvular aortic stenosis
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • autosomal dominant cutis laxa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00284 (409/144248) while in subpopulation NFE AF = 0.00383 (252/65798). AF 95% confidence interval is 0.00344. There are 0 homozygotes in GnomAd4. There are 173 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 409 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ELNNM_000501.4 linkc.1096+43_1096+50dupGTGTGTGT intron_variant Intron 18 of 32 ENST00000252034.12 NP_000492.2 P15502-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ELNENST00000252034.12 linkc.1096+11_1096+12insTGTGTGTG intron_variant Intron 18 of 32 1 NM_000501.4 ENSP00000252034.7 P15502-2

Frequencies

GnomAD3 genomes
AF:
0.00284
AC:
409
AN:
144144
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00298
Gnomad AMI
AF:
0.00338
Gnomad AMR
AF:
0.000763
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00163
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.000742
Gnomad MID
AF:
0.00329
Gnomad NFE
AF:
0.00383
Gnomad OTH
AF:
0.00101
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00189
AC:
2680
AN:
1416058
Hom.:
0
Cov.:
0
AF XY:
0.00185
AC XY:
1301
AN XY:
701830
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00294
AC:
95
AN:
32308
American (AMR)
AF:
0.00137
AC:
54
AN:
39484
Ashkenazi Jewish (ASJ)
AF:
0.000356
AC:
9
AN:
25300
East Asian (EAS)
AF:
0.000928
AC:
35
AN:
37712
South Asian (SAS)
AF:
0.00154
AC:
127
AN:
82432
European-Finnish (FIN)
AF:
0.000753
AC:
37
AN:
49144
Middle Eastern (MID)
AF:
0.00142
AC:
6
AN:
4228
European-Non Finnish (NFE)
AF:
0.00205
AC:
2228
AN:
1086986
Other (OTH)
AF:
0.00152
AC:
89
AN:
58464
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.296
Heterozygous variant carriers
0
205
410
616
821
1026
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00284
AC:
409
AN:
144248
Hom.:
0
Cov.:
0
AF XY:
0.00247
AC XY:
173
AN XY:
69950
show subpopulations
African (AFR)
AF:
0.00297
AC:
115
AN:
38764
American (AMR)
AF:
0.000762
AC:
11
AN:
14428
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3392
East Asian (EAS)
AF:
0.00164
AC:
8
AN:
4890
South Asian (SAS)
AF:
0.00229
AC:
10
AN:
4374
European-Finnish (FIN)
AF:
0.000742
AC:
7
AN:
9436
Middle Eastern (MID)
AF:
0.00355
AC:
1
AN:
282
European-Non Finnish (NFE)
AF:
0.00383
AC:
252
AN:
65798
Other (OTH)
AF:
0.00100
AC:
2
AN:
1996
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
19
39
58
78
97
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00136
Hom.:
744

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Supravalvar aortic stenosis Uncertain:1
Jul 24, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the effect of this variant on mRNA splicing is currently unknown. This variant has not been reported in the literature in individuals affected with ELN-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change falls in intron 18 of the ELN gene. It does not directly change the encoded amino acid sequence of the ELN protein. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.78
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10579871; hg19: chr7-73467650; API